These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33445465)

  • 1. Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer.
    Jönsson JM; Bååth M; Björnheden I; Sahin ID; Måsbäck A; Hedenfalk I
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
    Patel JN; Braicu I; Timms KM; Solimeno C; Tshiaba P; Reid J; Lanchbury JS; Darb-Esfahani S; Ganapathi MK; Sehouli J; Ganapathi RN
    Br J Cancer; 2018 Oct; 119(9):1060-1066. PubMed ID: 30318511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.
    Wen H; Feng Z; Ma Y; Liu R; Ou Q; Guo Q; Shen Y; Wu X; Shao Y; Bao H; Wu X
    BMC Cancer; 2022 May; 22(1):550. PubMed ID: 35578198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker Assessment of HR Deficiency, Tumor
    Stronach EA; Paul J; Timms KM; Hughes E; Brown K; Neff C; Perry M; Gutin A; El-Bahrawy M; Steel JH; Liu X; Lewsley LA; Siddiqui N; Gabra H; Lanchbury JS; Brown R
    Mol Cancer Res; 2018 Jul; 16(7):1103-1111. PubMed ID: 29724815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma.
    Takaya H; Nakai H; Takamatsu S; Mandai M; Matsumura N
    Sci Rep; 2020 Feb; 10(1):2757. PubMed ID: 32066851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
    Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
    Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Determinants of Homologous Recombination Deficiency across Human Cancers.
    Qing T; Wang X; Jun T; Ding L; Pusztai L; Huang KL
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial Cancers in
    Smith ES; Da Cruz Paula A; Cadoo KA; Abu-Rustum NR; Pei X; Brown DN; Ferrando L; Sebastiao APM; Riaz N; Robson ME; Soslow RA; Reis-Filho JS; Mandelker D; Weigelt B
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors.
    Zhao D; Wang A; Li Y; Cai X; Zhao J; Zhang T; Zhao Y; Dong Y; Zhou F; Li Y; Wang J
    J Natl Cancer Cent; 2024 Sep; 4(3):280-287. PubMed ID: 39281716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
    de Jonge MM; Auguste A; van Wijk LM; Schouten PC; Meijers M; Ter Haar NT; Smit VTHBM; Nout RA; Glaire MA; Church DN; Vrieling H; Job B; Boursin Y; de Kroon CD; Rouleau E; Leary A; Vreeswijk MPG; Bosse T
    Clin Cancer Res; 2019 Feb; 25(3):1087-1097. PubMed ID: 30413523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous Recombination Abnormalities Associated With
    Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A
    Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous recombination deficiency and ovarian cancer.
    Ledermann JA; Drew Y; Kristeleit RS
    Eur J Cancer; 2016 Jun; 60():49-58. PubMed ID: 27065456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca".
    Boussios S; Karathanasi A; Cooke D; Neille C; Sadauskaite A; Moschetta M; Zakynthinakis-Kyriakou N; Pavlidis N
    Diagnostics (Basel); 2019 May; 9(2):. PubMed ID: 31109041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between single-nucleotide polymorphism-based genomic instability assays and a next-generation sequencing-based homologous recombination deficiency test.
    Cristescu R; Liu XQ; Arreaza G; Chen C; Albright A; Qiu P; Marton MJ
    BMC Cancer; 2022 Dec; 22(1):1310. PubMed ID: 36517748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous Recombination Deficiency Score Determined by Genomic Instability in a Romanian Cohort.
    Rădoi VE; Țurcan M; Maioru OV; Dan A; Bohîlțea LC; Dumitrescu EA; Gheorghe AS; Stănculeanu DL; Thodi G; Loukas YL; Săbău ID
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Transcriptomic Signatures of Homologous Recombination Deficiency in Ovarian Cancers.
    Lee JJ; Kang HJ; Kim SS; Charton C; Kim J; Lee JK
    Adv Biol (Weinh); 2022 Dec; 6(12):e2200060. PubMed ID: 36116121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas.
    Milanesio MC; Giordano S; Valabrega G
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers.
    Jamieson A; Sobral de Barros J; Cochrane DR; Douglas JM; Shankar S; Lynch BJ; Leung S; Martin S; Senz J; Lum A; Drew Y; Gilks CB; Huntsman DG; McAlpine JN
    Clin Cancer Res; 2024 Jun; 30(11):2461-2474. PubMed ID: 38536067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations.
    Quesada S; Fabbro M; Solassol J
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for Homologous Recombination Deficiency in Cancer.
    Hoppe MM; Sundar R; Tan DSP; Jeyasekharan AD
    J Natl Cancer Inst; 2018 Jul; 110(7):704-713. PubMed ID: 29788099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.